Harrow, Inc. (HROW) vs Phibro Animal Health Corporation (PAHC)
- Harrow, Inc. HROW 27.28 −5.11%
- Phibro Animal Health Corporation PAHC 38.82 +2.21%
Harrow, Inc. and Phibro Animal Health Corporation are both Drug Manufacturers Specialty & Generic companies. Phibro Animal Health Corporation is the larger, with a market value of $1.5B against $1.1B — 1.4× the size. Harrow, Inc. has negative trailing earnings, so its P/E is not meaningful; Phibro Animal Health Corporation trades at 15.8×. Harrow, Inc. grew revenue faster over the last twelve months: 21.1% against 17.1%. Phibro Animal Health Corporation has the higher net margin (6.57% vs −13.5%) and the higher return on invested capital (11.7% vs −0.77%). Across the 20 metrics below, Phibro Animal Health Corporation leads on 17 and Harrow, Inc. on 3.
Valuation
Profitability
| Metric | HROW | PAHC | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 73.28% | 33.76% | 53.94% |
| Operating margin | (1.00%) | 12.81% | 0.00% |
| Net margin | (13.51%) | 6.57% | 0.00% |
| Free cash flow margin | (4.75%) | 0.65% | 0.00% |
| Return on equity | (116.07%) | 29.72% | (0.40%) |
| Return on assets | (9.77%) | 6.97% | (3.32%) |
| Return on invested capital | (0.77%) | 11.72% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack